Single and Multiple Ascending Dosing Administration of MF-300 in Healthy Participants
Clinical trial NCT07613684 · COMPLETED
Trial details
- NCT number
- NCT07613684
- Sponsor
- Epirium Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-20
- Primary completion
- 2025-10-09
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.